A commentary on 'Comparison of the efficacy of neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients: meta-analysis of randomized controlled trials'.
作者信息
Zhou Wenjie, Dan Jie, Zhu Mingjie, Wang Yonghong
机构信息
Department of Gastrointestinal Surgery, The People's Hospital of Leshan, LeShan, Sichuan Province, China.
出版信息
Int J Surg. 2025 Jun 1;111(6):4124-4125. doi: 10.1097/JS9.0000000000002402. Epub 2025 Apr 22.
Abstract
摘要
相似文献
1
A commentary on 'Comparison of the efficacy of neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients: meta-analysis of randomized controlled trials'.关于“局部晚期直肠癌患者新辅助化疗与新辅助放化疗疗效比较：随机对照试验的荟萃分析”的述评
Int J Surg. 2025 Jun 1;111(6):4124-4125. doi: 10.1097/JS9.0000000000002402. Epub 2025 Apr 22.
2
Oxaliplatin/fluorouracil-based adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery: a systematic review and meta-analysis of randomized controlled trials.新辅助放化疗和手术治疗局部进展期直肠癌后的奥沙利铂/氟尿嘧啶为基础的辅助化疗：随机对照试验的系统评价和荟萃分析。
Colorectal Dis. 2016 Aug;18(8):763-72. doi: 10.1111/codi.13381.
3
[Efficacy and safety of total neoadjuvant therapy versus neoadjuvant chemoradiotherapy in the treatment of locally advanced rectal cancer: a meta-analysis].全新辅助治疗与新辅助放化疗治疗局部晚期直肠癌的疗效和安全性：一项荟萃分析
Zhonghua Wei Chang Wai Ke Za Zhi. 2022 Jun 25;25(6):531-538. doi: 10.3760/cma.j.cn441530-20210806-00311.
4
Comparison of the efficacy of neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients: meta-analysis of randomized controlled trials.局部晚期直肠癌患者新辅助化疗与新辅助放化疗疗效比较：随机对照试验的荟萃分析
Int J Surg. 2025 Mar 1;111(3):2686-2696. doi: 10.1097/JS9.0000000000002262.
5
Evaluating the Impact of Induction and Consolidation Total Neoadjuvant Therapies Compared to Conventional Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Network Meta-analysis.评估诱导和巩固性全新辅助治疗与传统放化疗相比对局部晚期直肠癌的影响：一项系统评价和网状Meta分析
Dis Colon Rectum. 2025 Jun 1;68(6):687-701. doi: 10.1097/DCR.0000000000003687. Epub 2025 Mar 10.
6
Korean Society of Coloproctology (KSCP) trial of cONsolidation Chemotherapy for Locally advanced mid or low rectal cancer after neoadjUvant concurrent chemoraDiothErapy: a multicenter, randomized controlled trial (KONCLUDE).韩国结直肠外科学会（KSCP）新辅助同期放化疗后局部中低位进展期直肠癌巩固化疗的临床试验：一项多中心、随机对照试验（KONCLUDE）。
BMC Cancer. 2018 May 8;18(1):538. doi: 10.1186/s12885-018-4466-7.
7
Total Neoadjuvant Therapy (TNT) versus Standard Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.局部晚期直肠癌的全新辅助治疗（TNT）与标准新辅助放化疗：一项系统评价和荟萃分析
Oncologist. 2021 Sep;26(9):e1555-e1566. doi: 10.1002/onco.13824. Epub 2021 Jun 7.
8
Neoadjuvant chemotherapy and chemoradiotherapy versus chemoradiotherapy alone in high-risk locally advanced rectal cancer: A retrospective comparison of two Dutch tertiary referral centres.新辅助化疗及放化疗与单纯放化疗用于高危局部晚期直肠癌的比较：荷兰两家三级转诊中心的回顾性对比
Eur J Surg Oncol. 2025 May;51(5):109699. doi: 10.1016/j.ejso.2025.109699. Epub 2025 Feb 13.
9
Survival and complications after neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for locally advanced gastric cancer: a systematic review and meta-analysis.新辅助放化疗与新辅助化疗治疗局部晚期胃癌后的生存情况及并发症：一项系统评价和荟萃分析
Front Oncol. 2023 May 9;13:1177557. doi: 10.3389/fonc.2023.1177557. eCollection 2023.
10
[Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].[局部晚期高危直肠癌患者新辅助综合治疗的疗效与安全性分析]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Apr 25;22(4):349-356. doi: 10.3760/cma.j.issn.1671-0274.2019.04.007.
本文引用的文献
1
Comparison of the efficacy of neoadjuvant chemotherapy and neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients: meta-analysis of randomized controlled trials.局部晚期直肠癌患者新辅助化疗与新辅助放化疗疗效比较：随机对照试验的荟萃分析
Int J Surg. 2025 Mar 1;111(3):2686-2696. doi: 10.1097/JS9.0000000000002262.
2
Preoperative Treatment of Locally Advanced Rectal Cancer.局部进展期直肠癌的术前治疗。
N Engl J Med. 2023 Jul 27;389(4):322-334. doi: 10.1056/NEJMoa2303269. Epub 2023 Jun 4.
3
Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial.新辅助化疗 CAPOX 对比放化疗治疗未累及中胚层筋膜的局部进展期直肠癌（CONVERT）：一项 III 期试验的初步结果。
Ann Surg. 2023 Apr 1;277(4):557-564. doi: 10.1097/SLA.0000000000005780. Epub 2022 Dec 20.
4
Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial.新辅助改良 FOLFOX6 联合或不联合放疗对比氟尿嘧啶联合放疗治疗局部进展期直肠癌：中国 FOWARC 试验的最终结果。
J Clin Oncol. 2019 Dec 1;37(34):3223-3233. doi: 10.1200/JCO.18.02309. Epub 2019 Sep 26.
5
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.直肠癌：欧洲肿瘤内科学会临床实践指南之诊断、治疗及随访
Ann Oncol. 2017 Jul 1;28(suppl_4):iv22-iv40. doi: 10.1093/annonc/mdx224.
6
Preoperative versus postoperative chemoradiotherapy for rectal cancer.直肠癌术前与术后放化疗对比
N Engl J Med. 2004 Oct 21;351(17):1731-40. doi: 10.1056/NEJMoa040694.
Zotero 插件